AstraZeneca UK chief Chris Brinsmead has been chosen to head-up to the Association of the British Pharmaceutical Industry, taking over the reigns from current president Nigel Brooksby in April 2008.

Chris will take over from Nigel during a time that is likely to be just as busy for the ABPI, which is due to launch a revised Code of Conduct next year, primarily to bring it fully in-line with new guidelines recently issued by the European Federation of Pharmaceutical Industries and Associations.

Further explaining his duties, Chris said: “In taking over the reigns from Nigel Brooksby, I will continue to seek to ensure that patients have access to the appropriate medicines, that industry works in a way which meets the needs of professionals in the NHS, and that we can continue to focus on finding cures for the many unsolved medical needs at a cost which healthcare systems can afford”.

“I commit to work with all stakeholders to build on past successes so that future generations can have access to new innovative medicines which address unmet need. I will encourage openness, engagement and a willingness to work together in achieving these shared goals.”

Chris has a degree in Engineering and is a member of the Governance Board and Board of Management at the ABPI. He is married and has two daughters.

Unfortunately, he will not be answering any questions regarding his new appointment until nearer the time of his presidency, a spokesperson for the ABPI told PharmaTimes UK News.